Study design in osteoporosis: a European perspective
J A Kanis1, J M Alexandre, H G Bone
1WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, United Kingdom. W.J.Pointefract@sheffield.ac.uk
Summary
New osteoporosis treatments are available, but placebo-controlled trials remain crucial for efficacy testing. Superiority or equivalence studies are often impractical due to large sample sizes and unclear results.
Area of Science:
- Bone health research
- Clinical trial design
- Pharmacological efficacy studies
Background:
- Effective osteoporosis treatments exist, challenging traditional trial designs.
- Current recommendations favor superiority, equivalence, or non-inferiority trials over placebo controls.
- Large sample sizes and increased fracture burden are concerns in new trial designs.
Purpose of the Study:
- To evaluate the appropriateness of placebo-controlled trials for new osteoporosis agents.
- To discuss the limitations of superiority, equivalence, and non-inferiority studies in osteoporosis research.
- To address the ongoing need for placebo-controlled studies, potentially with adjusted durations.
Main Methods:
- Critical review of current clinical trial methodologies in osteoporosis.
- Analysis of the statistical and practical challenges of equivalence and non-inferiority trials.
- Examination of regulatory requirements for osteoporosis drug efficacy studies.
Main Results:
- Superiority, equivalence, and non-inferiority trials present significant challenges in osteoporosis, including large sample sizes and interpretational difficulties.
- Equivalence studies are particularly problematic due to high variance in active comparator effects.
- Placebo-controlled trials, despite challenges, may still be necessary for regulatory approval.
Conclusions:
- Placebo-controlled trials remain relevant for osteoporosis drug efficacy assessment.
- Alternative trial designs face substantial practical and statistical hurdles.
- Regulatory agencies may still require placebo-controlled studies, possibly of shorter duration.
Keywords:
Biomedical and Behavioral Research
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...